Market Tracker

10/22 6:06pm ET

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.74
Data as of 3:59pm ET
 +0.03 / +4.23%
Today’s Change
0.37
Today|||52-Week Range
1.85
+45.10%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.71
Today’s open0.71
Day’s range0.71 - 0.77
Volume1,457,865
Average volume (3 months)1,022,641
Market cap$126.6M
Dividend yield--
Data as of 3:59pm ET, 10/22/2014

Growth & Valuation

Earnings growth (last year)-16.67%
Earnings growth (this year)-90.48%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book8.25

Competitors

 Today’s
change
Today’s
% change
CRMECardiome Pharma Corp+0.20+2.62%
RLMDRelmada Therapeutics...0.000.00%
GLYCGlycoMimetics Inc-0.08-1.15%
MDWDMediwound Ltd-0.16-2.57%
Data as of 3:59pm ET, 10/22/2014

Financials

Next reporting dateDecember 3, 2014
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$0.00
Annual profit (last year)-$9.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Scientist
Chang Ho Ahn
Chief Executive Officer &
Director
Peter David Suzdak
Corporate headquarters
Rockville, Maryland

Forecasts